Cite Filings / CMPX / 0001193125-22-282853

Feed Companies Filings Check

Sign in

SC 13D

Beneficial Ownership Report

Compass Therapeutics, Inc. Filed 2022-11-14 Acc 0001193125-22-282853

Documents 1

SC 13D Beneficial Ownership Report , d421219dsc13d.htm

Around this filing

2022-11-14 SC 13D Beneficial Ownership Report
2022-11-10 4 Director bought 402,000 shares at $3.21 ($1,290,420)
2022-11-10 4 Director bought 402,000 shares at $3.21 ($1,290,420)
2022-11-10 SC 13D/A Beneficial Ownership Report
2022-11-10 3 Initial Statement of Ownership
2022-11-09 10-Q Quarterly Report
2020-06-29 SC 13D Beneficial Ownership Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading d421219dsc13d.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…